Eleven Therapeutics

siRNA
#Biotechnology platform #Eleven Therapeutics #Seed funding #siRNA #Therapeutics #Undecimal Bio

Seed financing to address ‘liver trap’ in siRNA therapeutic delivery 

Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, has announced an oversubscribed $18 million seed financing.   The company is a spin-out from Eleven Therapeutics and will use the funding to expand DELiveri, its AI-enabled platform for identifying conjugates that can direct RNA… Read More

#News